The calcium chloride-induced rodent model of abdominal aortic aneurysm

Atherosclerosis

Volumn 226, Issue 1, 2013, Pages 29-39

  Wang, Yutang ^a   Krishna, Smriti ^a   Golledge, Jonathan ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Abdominal aortic aneurysm; Calcification; Calcium chloride; Extracellular matrix; Inflammation; Matrix metalloproteinase

Indexed keywords

CALCIUM CHLORIDE; CHEMOKINE RECEPTOR CCR2; ELASTIN; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN; SECRETORY PHOSPHOLIPASE A2; STRESS ACTIVATED PROTEIN KINASE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ANIMAL MODEL; APOPTOSIS; CALCIFICATION; CELL INFILTRATION; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; CALCIUM CHLORIDE; DISEASE MODELS, ANIMAL; HUMANS; MICE; RATS;

EID: 84871392597     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.010     Document Type: Review

References (99)

1. Johnston K.W., Rutherford R.B., Tilson M.D., Shah D.M., Hollier L., Stanley J.C. Suggested standards for reporting on arterial aneurysms. Subcommittee on reporting standards for arterial aneurysms, Ad Hoc Committee on reporting standards, Society for vascular surgery and North American Chapter, International Society for cardiovascular surgery. J Vasc Surg 1991, 13:452-458.
2. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006, 26:2605-2613.
3. Gillum R.F. Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol 1995, 48:1289-1298.
4. Timaran C.H., Veith F.J., Rosero E.B., et al. Endovascular aortic aneurysm repair in patients with the highest risk and in-hospital mortality in the United States. Arch Surg 2007, 142:520-524. discussion 524-525.
5. Svensjo S., Bjorck M., Gurtelschmid M., Djavani Gidlund K., Hellberg A., Wanhainen A. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011, 124:1118-1123.
6. Choke E., Vijaynagar B., Thompson J., Nasim A., Bown M.J., Sayers R.D. Changing epidemiology of abdominal aortic aneurysms in England and Wales: older and more benign?. Circulation 2012, 125:1617-1625.
7. Norman P.E., Powell J.T. Site specificity of aneurysmal disease. Circulation 2010, 121:560-568.
8. Nordon I.M., Hinchliffe R.J., Loftus I.M., Thompson M.M. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011, 8:92-102.
9. Powell J.T., Greenhalgh R.M. Clinical practice. Small abdominal aortic aneurysms. N Engl J Med 2003, 348:1895-1901.
10. Bown M.J., Sutton A.J., Bell P.R., Sayers R.D. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg 2002, 89:714-730.
11. Basnyat P.S., Biffin A.H., Moseley L.G., Hedges A.R., Lewis M.H. Mortality from ruptured abdominal aortic aneurysm in Wales. Br J Surg 1999, 86:765-770.
12. Aoki H., Yoshimura K., Matsuzaki M. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy. J Mol Med (Berl) 2007, 85:1077-1088.
13. Brewster D.C., Cronenwett J.L., Hallett J.W., Johnston K.W., Krupski W.C., Matsumura J.S. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American association for vascular surgery and society for vascular surgery. J Vasc Surg 2003, 37:1106-1117.
14. Jones W.B., Taylor S.M., Kalbaugh C.A., et al. Lost to follow-up: a potential under-appreciated limitation of endovascular aneurysm repair. J Vasc Surg 2007, 46:434-440. discussion 440-431.
15. Hellenthal F.A., Buurman W.A., Wodzig W.K., Schurink G.W. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol 2009, 6:464-474.
16. Trollope A., Moxon J.V., Moran C.S., Golledge J. Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol 2011, 20:114-123.
17. Daugherty A., Cassis L.A. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004, 24:429-434.
18. Jayalath R.W., Mangan S.H., Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg 2005, 30:476-488.
19. Blumenthal H.T., Lansing A.I., Wheeler P.A. Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, ageing and disease. Am J Pathol 1944, 20:665-687.
20. Parr A., Buttner P., Shahzad A., Golledge J. Relation of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. Am J Cardiol 2010, 105:895-899.
21. Maier A., Gee M.W., Reeps C., Eckstein H.H., Wall W.A. Impact of calcifications on patient-specific wall stress analysis of abdominal aortic aneurysms. Biomech Model Mechanobiol 2010, 9:511-521.
22. Gertz S.D., Kurgan A., Eisenberg D. Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo. J Clin Invest 1988, 81:649-656.
23. Freestone T., Turner R.J., Higman D.J., Lever M.J., Powell J.T. Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits. Arterioscler Thromb Vasc Biol 1997, 17:10-17.
24. Chiou A.C., Chiu B., Pearce W.H. Murine aortic aneurysm produced by periarterial application of calcium chloride. J Surg Res 2001, 99:371-376.
25. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002, 110:625-632.
26. Yoshimura K., Aoki H., Ikeda Y., et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 2005, 11:1330-1338.
27. Kimura T., Yoshimura K., Aoki H., et al. Tenascin-C is expressed in abdominal aortic aneurysm tissue with an active degradation process. Pathol Int 2011, 61:559-564.
28. Hamblin M., Chang L., Zhang H., Yang K., Zhang J., Chen Y.E. Vascular smooth muscle cell peroxisome proliferator-activated receptor-gamma deletion promotes abdominal aortic aneurysms. J Vasc Surg 2010, 52:984-993.
29. Watanabe K., Fujioka D., Saito Y., et al. Group X secretory PLA2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice. Am J Physiol Heart Circ Physiol 2012, 302:H95-104.
30. MacTaggart J.N., Xiong W., Knispel R., Baxter B.T. Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation. Surgery 2007, 142:284-288.
31. Aoyama N., Suzuki J., Wang D., et al. Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metalloproteinase-2 induction. J Periodontal Res 2011, 46:176-183.
32. Kaneko H., Anzai T., Morisawa M., et al. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization. Atherosclerosis 2011, 217:350-357.
33. Prall A.K., Longo G.M., Mayhan W.G., et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 2002, 35:923-929.
34. Kaneko H., Anzai T., Takahashi T., et al. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm. Cardiovasc Res 2011, 91:358-367.
35. Yamanouchi D., Morgan S., Stair C., et al. Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model. J Vasc Surg 2012.
36. Sheth R.A., Maricevich M., Mahmood U. In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate. Atherosclerosis 2010, 212:181-187.
37. Xiong W., Knispel R., MacTaggart J., Greiner T.C., Weiss S.J., Baxter B.T. Membrane-type 1 matrix metalloproteinase regulates macrophage-dependent elastolytic activity and aneurysm formation in vivo. J Biol Chem 2009, 284:1765-1771.
38. Longo G.M., Buda S.J., Fiotta N., et al. MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery 2005, 137:457-462.
39. 2-induced rat aortal expansions as a surrogate culture model for study of elastogenic induction of human aneurysmal cells. Tissue Eng Part A 2011, 17:1945-1958.
40. Kothapalli C.R., Gacchina C.E., Ramamurthi A. Utility of hyaluronan oligomers and transforming growth factor-beta1 factors for elastic matrix regeneration by aneurysmal rat aortic smooth muscle cells. Tissue Eng Part A 2009, 15:3247-3260.
41. Isenburg J.C., Simionescu D.T., Starcher B.C., Vyavahare N.R. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 2007, 115:1729-1737.
42. Tsuruda T., Kato J., Hatakeyama K., et al. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res 2008, 102:1368-1377.
43. Karapolat S., Unlu Y., Erkut B., Kocak H., Erdogan F. Influence of indomethacin in the rat aneurysm model. Ann Vasc Surg 2006, 20:369-375.
44. Basalyga D.M., Simionescu D.T., Xiong W., Baxter B.T., Starcher B.C., Vyavahare N.R. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 2004, 110:3480-3487.
45. Tanaka A., Hasegawa T., Chen Z., Okita Y., Okada K. A novel rat model of abdominal aortic aneurysm using a combination of intraluminal elastase infusion and extraluminal calcium chloride exposure. J Vasc Surg 2009, 50:1423-1432.
46. Munezane T., Hasegawa T., Suritala Tanaka A., Okada K., Okita Y. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation. J Vasc Surg 2010, 52:967-974.
47. Morimoto K., Hasegawa T., Tanaka A., et al. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. J Vasc Surg 2012, 55:1749-1758.
48. Liu G., Huang Y., Lu X.W., et al. Optimization of the model of abdominal aortic aneurysm by co-incubation of calcium chloride and collagenase in rats. Saudi Med J 2009, 30:1049-1053.
49. Liu G., Huang Y., Lu X., et al. Identification and characteristics of microRNAs with altered expression patterns in a rat model of abdominal aortic aneurysms. Tohoku J Exp Med 2010, 222:187-193.
50. Crowther M., Goodall S., Jones J.L., Bell P.R., Thompson M.M. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall. Br J Surg 2000, 87:1391-1400.
51. Patel M.I., Melrose J., Ghosh P., Appleberg M. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 1996, 24:82-92.
52. Tazume H., Miyata K., Tian Z., et al. Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2012, 32:1400-1409.
53. Krishnaswamy G., Ajitawi O., Chi D.S. The human mast cell: an overview. Methods Mol Biol 2006, 315:13-34.
54. Boyle J.J., Weissberg P.L., Bennett M.R. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol 2003, 23:1553-1558.
55. Leskinen M., Wang Y., Leszczynski D., Lindstedt K.A., Kovanen P.T. Mast cell chymase induces apoptosis of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001, 21:516-522.
56. Newman K.M., Malon A.M., Shin R.D., Scholes J.V., Ramey W.G., Tilson M.D. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connect Tissue Res 1994, 30:265-276.
57. Dodd BR, Spence RA. Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature. Curr Vasc Pharmacol 2011;9:471-78.
58. Meijer CA, Stijnen T, Wasser MNJM, Hamming JF, van Bockel JH, Lindeman JH. Pharmaceutical aneurysm stabilization trial (PHAST trial, NTR 1345). The Geisinger health system international scientific meeting, Danville, United States; October 2011.
59. Dimusto P.D., Lu G., Ghosh A., et al. Increased JNK in males compared with females in a rodent model of abdominal aortic aneurysm. J Surg Res 2011.
60. Kajimoto K., Miyauchi K., Kasai T., et al. Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis 2009, 206:505-511.
61. Ferguson C.D., Clancy P., Bourke B., et al. Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J 2010, 159:307-313.
62. Golledge J., Norman P.E. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 2011, 217:57-63.
63. Chapman H.A., Riese R.J., Shi G.P. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997, 59:63-88.
64. Moran C.S., Clancy P., Biros E., et al. Association of PPAR gamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. Clin Endocrinol (Oxf) 2010, 72:128-132.
65. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
66. Katrancioglu N., Manduz S., Karahan O., et al. The role of the CCR2 gene polymorphism in abdominal aortic aneurysms. Angiology 2011, 62:140-143.
67. Morioka Y., Saiga A., Yokota Y., et al. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. Arch Biochem Biophys 2000, 381:31-42.
68. Saiga A., Morioka Y., Ono T., et al. Group X secretory phospholipase A(2) induces potent productions of various lipid mediators in mouse peritoneal macrophages. Biochim Biophys Acta 2001, 1530:67-76.
69. Fujioka D., Saito Y., Kobayashi T., et al. Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice. Circulation 2008, 117:2977-2985.
70. Henderson W.R., Chi E.Y., Bollinger J.G., et al. Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med 2007, 204:865-877.
71. Zack M., Boyanovsky B.B., Shridas P., et al. Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. Atherosclerosis 2011, 214:58-64.
72. Gong Y., Hart E., Shchurin A., Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 2008, 118:3012-3024.
73. Tsuruda T., Hatakeyama K., Nagamachi S., et al. Inhibition of development of abdominal aortic aneurysm by glycolysis restriction. Arterioscler Thromb Vasc Biol 2012, 32:1410-1417.
74. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995, 15:1145-1151.
75. Miller F.J., Sharp W.J., Fang X., Oberley L.W., Oberley T.D., Weintraub N.L. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 2002, 22:560-565.
76. Campa J.S., Greenhalgh R.M., Powell J.T. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987, 65:13-21.
77. Gandhi R.H., Irizarry E., Cantor J.O., et al. Analysis of elastin cross-linking and the connective tissue matrix of abdominal aortic aneurysms. Surgery 1994, 115:617-620.
78. Henderson E.L., Geng Y.J., Sukhova G.K., Whittemore A.D., Knox J., Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999, 99:96-104.
79. Harter L.P., Gross B.H., Callen P.W., Barth R.A. Ultrasonic evaluation of abdominal aortic thrombus. J Ultrasound Med 1982, 1:315-318.
80. Powell J. Models of arterial aneurysm: for the investigation of pathogenesis and pharmacotherapy-a review. Atherosclerosis 1991, 87:93-102.
81. Carrell T.W., Smith A., Burnand K.G. Experimental techniques and models in the study of the development and treatment of abdominal aortic aneurysm. Br J Surg 1999, 86:305-312.
82. Matsushita M., Nishikimi N., Sakurai T., Nimura Y. Relationship between aortic calcification and atherosclerotic disease in patients with abdominal aortic aneurysm. Int Angiol 2000, 19:276-279.
83. Siegel C.L., Cohan R.H., Korobkin M., Alpern M.B., Courneya D.L., Leder R.A. Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. AJR Am J Roentgenol 1994, 163:1123-1129.
84. Lindholt J.S. Aneurysmal wall calcification predicts natural history of small abdominal aortic aneurysms. Atherosclerosis 2008, 197:673-678.
85. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996, 98:2572-2579.
86. Choke E., Thompson M.M., Dawson J., et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 2006, 26:2077-2082.
87. Thompson M.M., Jones L., Nasim A., Sayers R.D., Bell P.R. Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1996, 11:464-469.
88. Isenburg J.C., Simionescu D.T., Vyavahare N.R. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials 2004, 25:3293-3302.
89. Pyo R., Lee J.K., Shipley J.M., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000, 105:1641-1649.
90. Palmieri D., Pane B., Barisione C., et al. Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development. J Surg Res 2011, 171:e237-246.
91. Zhang Q., Huang J.H., Xia R.P., et al. Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol. J Surg Res 2011, 167:e385-393.
92. Daugherty A., Cassis L.A., Lu H. Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. J Zhejiang Univ Sci B 2011, 12:624-628.
93. Sarda-Mantel L., Coutard M., Rouzet F., et al. 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26:2153-2159.
94. Proudfoot D., Skepper J.N., Hegyi L., Bennett M.R., Shanahan C.M., Weissberg P.L. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000, 87:1055-1062.
95. Ewence A.E., Bootman M., Roderick H.L., et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 2008, 103:e28-34.
96. Nadra I., Mason J.C., Philippidis P., et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?. Circ Res 2005, 96:1248-1256.
97. Cohen J.R., Keegan L., Sarfati I., Danna D., Ilardi C., Wise L. Neutrophil chemotaxis and neutrophil elastase in the aortic wall in patients with abdominal aortic aneurysms. J Invest Surg 1991, 4:423-430.
98. Cohen J.R., Sarfati I., Danna D., Wise L. Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms. Ann Surg 1992, 216:327-330. discussion 330-322.
99. Rajavashisth T.B., Xu X.P., Jovinge S., et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 1999, 99:3103-3109.